IsoPlexis Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 130
Employees
  • Latest Deal Type
  • Series C1
  • Latest Deal Amount
  • $45M
Latest Deal Amount
  • Investors
  • 9

IsoPlexis General Information

Description

Developer of a single-cell detection system intended to accelerate insights in the field of cancer. The company's precision engineering platform offers multiplexed single-cell analysis tools to capture the omic or full, end function from thousands of single cells in parallel to better understand the complex patient response, enabling clinicians to overcome the challenges of complex diseases and targeted therapies to a more highly precise & personalized stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Primary Office
  • 35 North East Industrial Road
  • Branford, CT 06405
  • United States
+1 (415) 000-0000

IsoPlexis Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IsoPlexis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C1) 01-Dec-2019 $45M 000.00 Completed Generating Revenue
7. Grant 21-Jun-2019 000 000.00 Completed Generating Revenue
6. Grant 01-Nov-2017 00.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Aug-2017 000.00 000.00 0000 Completed Generating Revenue
4. Grant 01-Jan-2016 00000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A2) 29-May-2015 00.000 00.000 00.00 Completed Generating Revenue
2. Grant 01-Jan-2015 $182K $1.3M Completed Generating Revenue
1. Early Stage VC (Series A) 29-Jul-2014 $1.3M $1.3M 00.000 Completed Generating Revenue
To view IsoPlexis’s complete valuation and funding history, request access »

IsoPlexis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 000,000 00.000000 00 000.0 000.0 00 000.0 00.000
Series B2 000,000 00.000000 00 000.00 000.00 00 000.00 00.00
Series B 000,000 00.000000 00 000.00 000.00 00 000.00 00.00
Series A2 293,180 $0.001000 8% $12.59 $12.59 1x $12.59 13.72%
Series A 253,862 $0.001000 8% $6.5 $6.5 1x $6.5 11.88%
To view IsoPlexis’s complete cap table history, request access »

IsoPlexis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a single-cell detection system intended to accelerate insights in the field of cancer. The company's precis
Discovery Tools (Healthcare)
Branford, CT
130 As of 2020
000.00
00000000000 000.00

0000

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000000000000
Wheeling, IL
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IsoPlexis Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 Corporation Wheeling, IL 00
To view IsoPlexis’s complete competitors history, request access »

IsoPlexis Executive Team (10)

Name Title Board Seat Contact Info
Sean Mackay Co-Founder, Chief Executive Officer & Board Member
John Strahley Chief Financial Officer
Peter Siesel Chief Commercial Officer
Carrie Carter Chief of Staff
Timothy McConnell Ph.D Senior Scientific Fellow
You’re viewing 5 of 10 executive team members. Get the full list »

IsoPlexis Board Members (11)

Name Representing Role Since
Daniel Wagner Connecticut Innovations Board Member 000 0000
Gregory Ho JD Spring Mountain Capital Board Director 000 0000
James Heath Ph.D Self Board Member and Member of Scientefic Advisory Board 000 0000
John Conley IsoPlexis Chairman of the Board 000 0000
Matthew Storeygard Connecticut Innovations Board Observer 000 0000
You’re viewing 5 of 11 board members. Get the full list »

IsoPlexis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IsoPlexis Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Northpond Ventures Venture Capital Minority 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
Ironwood Capital PE/Buyout Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »